-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Supernus Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2011 to Q1 2024.
- Supernus Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $20.7M, a 0.72% increase year-over-year.
- Supernus Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $85.5M, a 162% increase from 2021.
- Supernus Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $32.6M, a 79.7% increase from 2020.
- Supernus Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2020 was $18.1M, a 172% increase from 2019.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)